BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2128239)

  • 21. Chemopreventive efficacy of all-trans-retinoic acid in biodegradable microspheres against epithelial cancers: results in a 4-nitroquinoline 1-oxide-induced oral carcinogenesis model.
    Choi Y; Kim SY; Park K; Yang J; Cho KJ; Kwon HJ; Byun Y
    Int J Pharm; 2006 Aug; 320(1-2):45-52. PubMed ID: 16730144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can we prevent malignancy by treating premalignant lesions?
    Holmstrup P
    Oral Oncol; 2009 Jul; 45(7):549-50. PubMed ID: 18952490
    [No Abstract]   [Full Text] [Related]  

  • 23. [COX-2 inhibitors: a novel way to prevent and treat the carcinogenesis of oral mucosa].
    Shi J; Chen QM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 May; 40(3):262-4. PubMed ID: 15938900
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of Gynostemma pentaphyllum mak (GP) on carcinogenesis of the golden hamster cheek pouch induced by DMBA].
    Zhou Z; Wang Y; Zhou Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Sep; 31(5):267-70. PubMed ID: 9592251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
    Chen HM; Chen CT; Yang H; Kuo MY; Kuo YS; Lan WH; Wang YP; Tsai T; Chiang CP
    Oral Oncol; 2004 Jul; 40(6):630-7. PubMed ID: 15063392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the biology of oral cancer and chemoprevention.
    Lingen MW
    CDS Rev; 1998; 91(4):24-8. PubMed ID: 9760890
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of laser vascular targeting and retinoic acid in oral cancer inhibition.
    Polavaram R; Fuentes CF; Shapshay SM; Wang Z
    Laryngoscope; 2003 Apr; 113(4):715-9. PubMed ID: 12671434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model.
    Heber EM; Aromando RF; Trivillin VA; Itoiz ME; Nigg DW; Kreimann EL; Schwint AE
    Arch Oral Biol; 2007 Mar; 52(3):273-9. PubMed ID: 17137553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of topically garlic solution painting on experimental oral precancer and oral cancer in rats].
    Tang Z; Shen Z; Liu S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Jul; 30(4):232-4. PubMed ID: 8745449
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of 13-CIS retinoids on premalignant and malignant cells of lung origin.
    Saccomanno G; Moran PG; Schmidt R; Hartshorn DF; Brian DA; Dreher WH; Sowada BJ
    Acta Cytol; 1982; 26(1):78-85. PubMed ID: 7039202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprevention of squamous cell carcinoma of the oral cavity.
    Brown KS; Kane MA
    Otolaryngol Clin North Am; 2006 Apr; 39(2):349-63. PubMed ID: 16580916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
    Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH
    Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [How to improve the diagnostic and therapeutic levels of oral premalignant lesions].
    Zhou ZT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):89-91. PubMed ID: 15842851
    [No Abstract]   [Full Text] [Related]  

  • 34. Altered cytokeratin expression during chemoprevention of hamster buccal pouch carcinogenesis by S-allylcysteine.
    Balasenthil S; Rao KS; Nagini S
    Pol J Pharmacol; 2003; 55(5):793-8. PubMed ID: 14704476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of candidal infection on the hyperplastic oral epithelium].
    Zhang KH; Wang HJ; Qin JX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Nov; 29(6):339-41, 384. PubMed ID: 7743876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Out of the mouths of babes: oral premalignant lesions and use of alternative tobacco products.
    Trock B
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):637-8. PubMed ID: 10919730
    [No Abstract]   [Full Text] [Related]  

  • 37. Pilot randomized phase II study of celecoxib in oral premalignant lesions.
    Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO
    Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regression by vitamin E of experimental oral cancer.
    Shklar G; Schwartz J; Trickler DP; Niukian K
    J Natl Cancer Inst; 1987 May; 78(5):987-92. PubMed ID: 3472005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereological analysis of histological parameters in experimental premalignant hamster cheek pouch epithelium.
    Franklin CD; Smith CJ
    J Pathol; 1980 Mar; 130(3):201-15. PubMed ID: 6772750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary immunologic studies on retinoid inhibition of experimental carcinogenesis.
    Sonis S; Shklar G
    J Oral Med; 1981; 36(4):117-9. PubMed ID: 6799629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.